Europe Pharmaceuticals & Healthcare Views

Pages

Price Pressures For Biosimilars To Rise

Governments in Western Europe are to remain committed to fiscal consolidation and will continue to target the healthcare sector and the prescription drugs sector in particular - a large recipient of...

Read article ›
Patent Expiries Hurt Exports

Uptake of generic drugs following patent expiries will become swifter. This trend will reduce costs for governments, out-of-pocket payers and insurance companies, which is increasingly important as...

Read article ›
NICE Recommends Sovaldi

NICE's preliminary recommendation of Sovaldi for the most common types of hepatitis C has strengthened Gilead's case for premium pricing. Having convinced the most stringent regulator in Europe, the...

Read article ›

Pages